
Genetic Study Launched Amid Pancreatic Concerns Over Weight Loss Medications
New Study to Explore Genetic Risks Behind Pancreatic Reactions to Weight Loss Injections British health authorities have launched an investigation into reports of pancreatic complications associated with weight loss medications such as Ozempic, Wegovy, and Mounjaro. The research, led by the Medicines and Healthcare products Regulatory Agency (MHRA) in collaboration











